Senate “Tripartisan” Medicare Rx Drug Bill To Have 50% Copay, $35 Premium
Executive Summary
The Medicare prescription drug bill under development by a five-member "tripartisan" coalition within the Senate Finance Committee includes a 50% copay and a $35 monthly premium
You may also be interested in...
Rx Cost-Effectiveness Data Requirement Would Raise Prices – AstraZeneca
Requiring pharmaceutical companies to collect cost-effectiveness data would lead to higher Rx pricing, AstraZeneca CEO Tom McKillop said during the company's annual business review Nov. 7
Rx Cost-Effectiveness Data Requirement Would Raise Prices – AstraZeneca
Requiring pharmaceutical companies to collect cost-effectiveness data would lead to higher Rx pricing, AstraZeneca CEO Tom McKillop said during the company's annual business review Nov. 7
Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
The transfer of control in the Senate puts Sen. Orrin Hatch (R-Utah) in position to have greater influence in guiding generic drug reform legislation